1. Home
  2. NWBI vs TVTX Comparison

NWBI vs TVTX Comparison

Compare NWBI & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWBI
  • TVTX
  • Stock Information
  • Founded
  • NWBI 1896
  • TVTX 2008
  • Country
  • NWBI United States
  • TVTX United States
  • Employees
  • NWBI N/A
  • TVTX N/A
  • Industry
  • NWBI Major Banks
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWBI Finance
  • TVTX Health Care
  • Exchange
  • NWBI Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • NWBI 1.7B
  • TVTX 1.5B
  • IPO Year
  • NWBI N/A
  • TVTX N/A
  • Fundamental
  • Price
  • NWBI $11.49
  • TVTX $16.97
  • Analyst Decision
  • NWBI Hold
  • TVTX Strong Buy
  • Analyst Count
  • NWBI 1
  • TVTX 16
  • Target Price
  • NWBI $15.00
  • TVTX $33.40
  • AVG Volume (30 Days)
  • NWBI 1.2M
  • TVTX 1.3M
  • Earning Date
  • NWBI 07-29-2025
  • TVTX 08-06-2025
  • Dividend Yield
  • NWBI 6.87%
  • TVTX N/A
  • EPS Growth
  • NWBI 38.60
  • TVTX N/A
  • EPS
  • NWBI 1.11
  • TVTX N/A
  • Revenue
  • NWBI $561,855,000.00
  • TVTX $333,865,000.00
  • Revenue This Year
  • NWBI $7.42
  • TVTX $71.61
  • Revenue Next Year
  • NWBI $11.81
  • TVTX $43.45
  • P/E Ratio
  • NWBI $10.45
  • TVTX N/A
  • Revenue Growth
  • NWBI 14.22
  • TVTX 87.94
  • 52 Week Low
  • NWBI $10.75
  • TVTX $8.09
  • 52 Week High
  • NWBI $15.42
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • NWBI 23.67
  • TVTX 64.00
  • Support Level
  • NWBI $11.61
  • TVTX $15.60
  • Resistance Level
  • NWBI $11.75
  • TVTX $17.46
  • Average True Range (ATR)
  • NWBI 0.27
  • TVTX 0.76
  • MACD
  • NWBI -0.14
  • TVTX 0.16
  • Stochastic Oscillator
  • NWBI 2.79
  • TVTX 93.61

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: